Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,654.00    -60.00 (-3.50%)
Bid:
1,664.00
Ask:
1,678.00
Spread: 14.00 (0.841%)
Market Cap: £487.13m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

AGM & Q1 Trading Update

30 Jan 2026 07:00

RNS Number : 0010R
Avon Technologies Plc
30 January 2026
 

30 January 2026 FOR IMMEDIATE RELEASE

 

 

AVON TECHNOLOGIES PLC

("Avon" or "the Group")

 

AGM & Q1 Trading Update

 

Continued strong demand. Full year guidance unchanged

 

Avon Technologies plc issues a trading update for the first quarter of the 2026 financial year ("Q1"), ahead of the Group's Annual General Meeting ("AGM"), which will be held at its Melksham facility at 10:30am today.

 

Avon Protection has continued its positive momentum with a record start to the year supported by sustained demand for our CBRN (Chemical, Biological, Radiological, and Nuclear) protection products, good operational gearing and a healthy order book and sales pipeline.

 

Team Wendy maintains a strong order book but saw a slower first quarter. The U.S. government shutdown delayed product testing and deliveries, which contributed to lower‑than‑expected Department of War and federal revenue in Q1. Margin was also held back by the planned increase in investment ahead of ramping production rates in Q2. Assuming no further extended government shutdowns, we expect these impacts to be temporary, with higher revenue, unwind of higher inventories and improved operational gearing expected over the remainder of the year.

 

At the Group level, we continue to anticipate full year performance consistent with the guidance provided at FY25 results in November, underpinned by continued robust demand for the Group's protective technologies.

 

 

Jos Sclater, Chief Executive Officer, commented:

"The first phase of our strategy to enhance operational performance through continuous improvement continues to deliver a stronger, more sustainable business. While there is still a lot to do to improve operational efficiency and productivity in our Cleveland facility, the momentum and capability we have built in our people is clear, we are making progress.

 

Having stabilised, strengthened and transformed Avon over the last three years, 2026 will see an increased focus on the growth stage of our strategy. We are investing across key programmes and new products that will strengthen our competitive position and expand our addressable markets. We are already seeing some promising early results.

 

We remain on track to meet or exceed our FY26 financial targets and look forward to sharing the next phase of our strategic development alongside our Interim and Full Year results."

 

AGM Presentation and Interim Results date

A presentation covering our recent continuous improvement activities and product innovation will be held at the AGM and will be available on our website later today: www.avon-technologiesplc.com

 

Avon will report Interim Results for the six months ending 31 March 2026 on 13 May 2026.

 

 

 

 

 

 

 

 

For further enquiries, please contact:

Avon Technologies plc

Jos Sclater, Chief Executive Officer

Rich Cashin, Chief Financial Officer investor.relations@avon-technologiesplc.com

Gabriella Colley, Corporate Affairs Director +44 7891 206 239

Sodali & Co

Pete Lambie avontechnologies@sodali.com

Tilly Abraham +44 7855 432 699

 

 

About Avon Technologies plc:

Avon Technologies is a Military and Law Enforcement protective equipment specialist. Our products are trusted to protect over 4 million service personnel and first responders in over 70 markets around the world.

 

Driven by a culture ofcontinuous improvement, we empower every individual in our organisation to identify opportunities and implement meaningful change. This commitment fuels our innovation and ensures we're constantly advancing our mission: to provide unparalleled protection for those who protect us. 

 

Our business is structured around two Strategic Business Units: 

· Avon Protection: a leading provider of advanced respiratory and integrated CBRN protective systems. 

· Team Wendy: a specialist in high-performance ballistic and impact protection helmet systems. 

 

For further information, please visit our websitewww.avon-technologiesplc.com 

Legal Entity Identifier: 213800JM1AN62REBWA71 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLMLTMTJTBPF
Date   Source Headline
1st Feb 20183:58 pmRNSResult of AGM
1st Feb 20187:00 amRNSAGM Statement
29th Jan 20187:00 amRNSUS Department of Defense Mask Systems Order
24th Jan 20185:38 pmRNSHolding(s) in Company
24th Jan 201811:44 amRNSHolding(s) in Company
9th Jan 20188:52 amRNSDirector/PDMR Shareholding
20th Dec 201712:16 pmRNSHolding(s) in Company
18th Dec 201710:18 amRNSNotice of Annual Report and Accounts and AGM
6th Dec 20173:39 pmRNSDirector/PDMR Shareholding
6th Dec 20172:14 pmRNSDirector/PDMR Shareholding
6th Dec 20177:00 amRNSUS Department of Defense Mask Systems Order
30th Nov 20174:20 pmRNSDirector/PDMR Shareholding
29th Nov 201711:10 amRNSDirector/PDMR Shareholding
24th Nov 20174:39 pmRNSDirector/PDMR Shareholding
15th Nov 20177:00 amRNSFinal Results
8th Nov 20177:00 amRNSAward of US JE-RDAP CBRNe framework contract
7th Nov 201712:15 pmRNSDirector/PDMR Shareholding
3rd Nov 201712:30 pmRNSPreferred bidder nomination
6th Oct 20173:42 pmRNSDirector/PDMR Shareholding
20th Sep 20175:01 pmRNSHolding(s) in Company
15th Sep 20177:00 amRNSPre-close trading update
12th Sep 20179:13 amRNSDirector/PDMR Shareholding
8th Sep 20179:07 amRNSDirector/PDMR Shareholding
4th Sep 201711:06 amRNSHolding(s) in Company
31st Aug 20174:08 pmRNSDirector/PDMR Shareholding
21st Aug 20172:06 pmRNSHolding(s) in Company
21st Aug 20171:53 pmRNSHolding(s) in Company
17th Aug 20177:00 amRNSAppointment of Corporate Broker
14th Aug 20179:59 amRNSDirector/PDMR Shareholding
9th Aug 201710:16 amRNSDirector/PDMR Shareholding
8th Aug 20173:33 pmRNSDirector/PDMR Shareholding
8th Aug 20171:23 pmRNSHolding(s) in Company
31st Jul 201711:03 amRNSDirector/PDMR Shareholding
6th Jul 20171:18 pmRNSDirectors'/PDMR Shareholdings - SIP
6th Jun 201711:51 amRNSDirector/PDMR Shareholding
23rd May 20177:00 amRNSContract Award
16th May 20177:00 amRNSHalf-year Report
10th May 20177:00 amRNSDirectorate Change
8th May 201712:31 pmRNSDirector/PDMR Shareholding
6th Apr 20174:03 pmRNSDirector/PDMR Shareholding
7th Mar 201710:34 amRNSDirector/PDMR Shareholding
17th Feb 20175:45 pmRNSHolding(s) in Company
15th Feb 20172:34 pmRNSDirector/PDMR Shareholding
15th Feb 20177:00 amRNSDirectorate Change
8th Feb 20174:11 pmRNSDirector/PDMR Shareholding
3rd Feb 20175:22 pmRNSHolding(s) in Company
2nd Feb 20175:13 pmRNSResult of AGM
2nd Feb 20177:00 amRNSTrading Update
26th Jan 20179:37 amRNSHolding(s) in Company
9th Jan 201710:20 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.